IFN-α induces barrier destabilization and apoptosis in renal proximal tubular epithelium

American Journal of Physiology - Cell Physiology

Volumn 294, Issue 1, 2008, Pages

  Lechner, Judith ^a   Malloth, Nadia ^a   Seppi, Thomas ^a   Beer, Bea ^a   Jennings, Paul ^a   Pfaller, Walter ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Caspase; Cell death; Cytokines; Interferon; Transepithelial electrical resistance

Indexed keywords

ALPHA INTERFERON; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 3 INHIBITOR; CASPASE 8; CASPASE 8 INHIBITOR; CASPASE 9; CASPASE 9 INHIBITOR; CYCLOSPORIN A; DNA; DNA FRAGMENT; LACTATE DEHYDROGENASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DENDRITIC CELL; ELECTRON MICROSCOPY; ENZYME INHIBITION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; KIDNEY PROXIMAL TUBULE; MACROPHAGE ACTIVATION; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; SWINE; VIRUS INFECTION;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 8; CASPASE 9; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CYSTEINE PROTEINASE INHIBITORS; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC IMPEDANCE; ENZYME ACTIVATION; EPITHELIAL CELLS; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON ALFA-2B; KIDNEY TUBULES, PROXIMAL; L-LACTATE DEHYDROGENASE; LLC-PK1 CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; SWINE; TIME FACTORS;

EID: 38349121006     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00120.2007     Document Type: Article

References (39)

1. Adams JM. Ways of dying: multiple pathways to apoptosis. Genes Dev 17: 2481-2495, 2003.
2. Al Harbi A, Al Ghamdi S, Subaity Y, Khalil A. Interferon-induced renal failure in nephrotic syndrome. Nephrol Dial Transplant 13: 1316-1318, 1998.
3. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 281: 1305-1308, 1998.
4. Averbuch S, Austin H, Sherwin S, Antonovych T, Bunn P, Longo D. Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides. N Engl J Med 310: 32-35, 1984.
5. Balda MS, Matter K. Epithelial cell adhesion and the regulation of gene expression. Trends Cell Biol 13: 310-318, 2003.
6. Basso E, Fante L, Fowlkes J, Petronilli V, Forte MA, Bernardi P. Properties of the permeability transition pore in mitochondria devoid of cyclophilin D. J Biol Chem 280: 18558-18561, 2005.
7. Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84: 869-901, 2004.
8. Belardelli F, Ferrantini M. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol 23: 201-208, 2002.
9. Broker LE, Kruyt FAE, Giaccone G. Cell death independent of caspases: a review. Clin Cancer Res 11: 3155-3162, 2005.
10. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 171: 6164-6172, 2003.
11. Chawla-Sarkar M, Lindner D, Liu Y, Williams B, Sen G, Silverman R, Borden E. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8: 237-249, 2003.
12. Fahal IH, Murry N, Chu P, Bell GM. Acute renal failure during interferon treatment. Br Med J 306: 973, 1993.
13. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 305: 626-629, 2004.
14. Healy E, Dempsey M, Lally C, Ryan M. Apoptosis and necrosis: mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line. Kidney Int 54: 1955-1966, 1998.
15. Izzedine H, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 45: 804-817, 2005.
16. Jonasch E, Haluska FG. Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities. Oncologist 6: 34-55, 2001.
17. Kappos L, Weinshenker B, Pozzilli C, Thompson AJ, Dahlke F, Beckmann K, Polman C, McFarland H; European (EU-SPMS) Interferon β-1b in Secondary Progressive Multiple Sclerosis Trial Steering Committee and Independent Advisory Board; North American (NASPMS) Interferon β-1b in Secondary Progressive Multiple Sclerosis Trial Steering Committee and Independent Advisory Board. Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials. Neurology 63: 1779-1787, 2004.
18. Korsmeyer S, Wei M, Saito M, Weiler S, Oh K, Schlesinger P. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 7: 1166-1173, 2000.
19. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99-163, 2007.
20. Kurschel E, Metz-Kurschel U, Niederle N, Aulbert E. Investigations on the subclinical and clinical nephrotoxicity of interferon alpha-2B in patients with myeloproliferative syndromes. Ren Fail 13: 87-93, 1991.
21. Lavrik I, Golks A, Krammer PH. Death receptor signaling. J Cell Sci 118: 265-267, 2005.
22. Leaman DW, Chawla-Sarkar M, Vyas K, Reheman M, Tamai K, Toji S, Borden EC. Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis. J Biol Chem 277: 28504-28511, 2002.
23. Lechner J, Krall M, Netzer A, Radmayr C, Ryan M, Pfaller W. Effects of interferon alpha-2b on barrier function and junctional complexes of renal proximal tubular LLC-PK1 cells. Kidney Int 55: 2178-2191, 1999.
24. Lechner J, Pfaller W. Interferon alpha2b increases paracellular permeability of renal proximal tubular LLC-PK1 cells via a mitogen activated protein kinase signaling pathway. Ren Fail 23: 573-588, 2001.
25. Madara J. Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological rearrangement of tight junctions. J Membr Biol 116: 177-184, 1990.
26. Murata M, Kojima T, Yamamoto T, Go M, Takano K, Osanai M, Chiba H, Sawada N. Down-regulation of survival signaling through MAPK and Akt in occludin-deficient mouse hepatocytes in vitro. Exp Cell Res 310: 140-151, 2005.
27. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271-279, 1991.
28. Ohdo S, Wang DS, Koyanagi S, Takane H, Inoue K, Aramaki H, Yukawa E, Higuchi S. Basis for dosing time-dependent changes in the antiviral activity of interferon-alpha in mice. J Pharmacol Exp Ther 294: 488-493, 2000.
29. Padanilam BJ. Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol 284: F608-F627, 2003.
30. Papageorgiou A, Lashinger L, Millikan R, Grossman HB, Benedict W, Dinney CPN, McConkey DJ. Role of tumor necrosis factor-related apoptosis-inducing ligand in interferon-induced apoptosis in human bladder cancer cells. Cancer Res 64: 8973-8979, 2004.
31. Parker M, Atkins M, Ucci A, Levey A. Rapidly progressive glomerulonephritis after immunotherapy for cancer. J Am Soc Nephrol 5: 1740-1744, 1995.
32. Rosenblatt J, Raff MC, Cramer LP. An epithelial cell destined for apoptosis signals its neighbors to extrude it by an actin- and myosin-dependent mechanism. Curr Biol 11: 1847-1857, 2001.
33. Rostaing L, Modesto A, Baron E, Cisterne J, Chabannier M, Durand D. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. Nephron 74: 512-516, 1996.
34. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 14: 778-809, 2001.
35. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 286: C1213-C1228, 2004.
36. Wadler S, Schwartz EL. New advances in interferon therapy of cancer. Oncologist 2: 254-267, 1997.
37. Wills R. Clinical pharmacokinetics of interferons. Clin Pharmacokinet 19: 390-399, 1990.
38. Yu ASL, McCarthy KM, Francis SA, McCormack JM, Lai J, Rogers RA, Lynch RD, Schneeberger EE. Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am J Physiol Cell Physiol 288: C1231-C1241, 2005.
39. Zhang Y, Gorelik J, Sanchez D, Shevchuk A, Lab M, Vodyanoy I, Klenerman D, Edwards C, Korchev Y. Scanning ion conductance microscopy reveals how a functional renal epithelial monolayer maintains its integrity. Kidney Int 68: 1071-1077, 2005.